CAM
CBIO

ClariVest Asset Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

ClariVest Asset Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,688
Closed -$508K – 780
2021
Q1 		$508K Buy
1,688
+388
+30% +$117K 0.02% 410
2020
Q4 		$489K Sell
1,300
-19
-1% -$7.15K 0.02% 387
2020
Q3 		$405K Sell
1,319
-82
-6% -$25.2K 0.01% 378
2020
Q2 		$527K Buy
+1,401
New +$527K 0.01% 395